{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:58:09Z","timestamp":1794441489487,"version":"4.9.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:p>Primary cutaneous marginal zone lymphoproliferative disorder (PCMZL) and primary cutaneous CD4<jats:sup>+<\/jats:sup> small\/medium T-cell lymphoproliferative disorder (CD4<jats:sup>+<\/jats:sup> TLPD) are indolent lymphoproliferative disorders. However, cases with overlapping features can be challenging. We identified 56 CD4<jats:sup>+<\/jats:sup> TLPD and 38 PCMZL cases from our pathology archives. Clinical, morphologic, and immunophenotypic features were reviewed. Polymerase chain reaction for immunoglobulin (IG) and T-cell receptor gamma (TRG) gene rearrangements were analyzed. Next-generation sequencing studies were performed on 26 cases with adequate material, 19 with CD4<jats:sup>+<\/jats:sup> TLPD, and 7 with PCMZL. CD4<jats:sup>+<\/jats:sup> TLPD presented mostly (91%) as solitary lesions, located in the head and neck area (64%), while PCMZL occurred mostly in the upper extremity (47%) and trunk (34%). Lesions were sometimes multiple (40%) and recurrences (67%) were more common. Cases of PCMZL had an increase in reactive CD3<jats:sup>+<\/jats:sup> T cells, with frequent programmed cell death protein 1 expression, whereas cases of CD4<jats:sup>+<\/jats:sup> TLPD often contained abundant reactive B cells. Twenty-five cases were identified as having overlapping features: 6 cases of PCMZL were clonal for both IG and TRG; 11 cases of CD4<jats:sup>+<\/jats:sup> TLPD were clonal for IG and TRG and 6 cases of CD4<jats:sup>+<\/jats:sup> TLPD had light chain\u2013restricted plasma cells. By next-generation sequencing, 23 variants were detected in 15 genes, with PCMZL more likely to show alterations, most commonly affecting TNFAIP3 and FAS, altered in 5 cases. Both entities have an indolent clinical course with response to conservative therapy and management, and warrant interpretation as a lymphoproliferative disorder rather than overt lymphoma.<\/jats:p>","DOI":"10.1097\/pas.0000000000001984","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T16:03:32Z","timestamp":1672848212000},"page":"344-353","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":32,"title":["Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4+ Small\/Medium T-Cell Lymphoproliferative Disorder"],"prefix":"10.1097","volume":"47","author":[{"given":"Ifeyinwa E.","family":"Obiorah","sequence":"first","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah","family":"Karrs","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of California San Francisco Medical Center, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo J.","family":"Karai","sequence":"additional","affiliation":[{"name":"Global Pathology, Sonic Health Care, Miami Lakes, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinh Hoc-Tran","family":"Pham","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thu Anh","family":"Pham","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiang","family":"Xi","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Raffeld","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000212118","article-title":"Solitary small- to medium-sized pleomorphic T-cell nodules of undetermined significance: clinical, histopathological, immunohistochemical and molecular analysis of 26 cases","volume":"219","author":"Leinweber","year":"2009","journal-title":"Dermatology"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/DAD.0b013e31819f19bb","article-title":"Primary cutaneous CD4+ small-\/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases","volume":"31","author":"Beltraminelli","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/PAS.0000000000001470","article-title":"Primary cutaneous CD4+ small\/medium T-cell lymphoproliferative disorders: a clinical, pathologic, and molecular study of 60 cases presenting with a single lesion: a multicenter study of the French Cutaneous Lymphoma Study Group","volume":"44","author":"Beltzung","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAS.0b013e31818e52fe","article-title":"Primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers","volume":"33","author":"Rodr\u00edguez Pinilla","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1200\/JCO.2008.16.1307","article-title":"Primary cutaneous small\/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome","volume":"26","author":"Garcia-Herrera","year":"2008","journal-title":"J Clin Oncol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/modpathol.2008.40","article-title":"Primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior","volume":"21","author":"Grogg","year":"2008","journal-title":"Mod Pathol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.critrevonc.2009.09.003","article-title":"Primary cutaneous marginal zone lymphoma","volume":"74","author":"Dalle","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3181f72835","article-title":"Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets","volume":"34","author":"Edinger","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/PAS.0000000000001363","article-title":"Class-switched primary cutaneous marginal zone lymphomas are frequently IgG4-positive and have features distinct from IgM-positive cases","volume":"43","author":"Carlsen","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/PAI.0000000000000462","article-title":"IgG4 expression in primary cutaneous marginal zone lymphoma: a multicenter study","volume":"26","author":"De Souza","year":"2018","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/cup.12254","article-title":"Programmed death-1 expression in cutaneous B-cell lymphoma","volume":"41","author":"\u00c7etin\u00f6zman","year":"2014","journal-title":"J Cutan Pathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/PAS.0000000000001414","article-title":"Expansion of PD1-positive T cells in nodal marginal zone lymphoma: a potential diagnostic pitfall","volume":"44","author":"Egan","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.anndiagpath.2019.04.013","article-title":"Monoclonal plasma cell infiltrates in the setting of cutaneous follicular helper T cell lymphoproliferative disorders","volume":"40","author":"Magro","year":"2019","journal-title":"Ann Diagn Pathol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.dad.0000211514.98230.ba","article-title":"Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement","volume":"28","author":"Kazakov","year":"2006","journal-title":"Am J Dermatopathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nm0896-906","article-title":"Large clonal expansions of CD8+ T cells in acute infectious mononucleosis","volume":"2","author":"Callan","year":"1996","journal-title":"Nat Med"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/1024533031000107505","article-title":"Application of the molecular analysis of the T-cell receptor repertoire in the study of immune-mediated hematologic diseases","volume":"8","author":"Plasilova","year":"2003","journal-title":"Hematology"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1038\/s41379-020-0568-2","article-title":"T-cell clones of uncertain significance are highly prevalent and show close resemblance to T-cell large granular lymphocytic leukemia. Implications for laboratory diagnostics","volume":"33","author":"Shi","year":"2020","journal-title":"Mod Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0167-5699(99)01472-3","article-title":"T-cell clonality in immune responses","volume":"20","author":"Maini","year":"1999","journal-title":"Immunol Today"},{"key":"R22-20250608","first-page":"3188","article-title":"Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders","volume":"5","author":"Stewart","year":"2021","journal-title":"Blood Adv"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41379-019-0385-7","article-title":"Navigating the cutaneous B-cell lymphomas: avoiding the rocky shoals","volume":"33","author":"Jaffe","year":"2020","journal-title":"Mod Pathol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.0303-6987.2003.00167.x","article-title":"Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases","volume":"31","author":"Colli","year":"2004","journal-title":"J Cutan Pathol"},{"issue":"suppl:","key":"R26-20250608","first-page":"S38","article-title":"Primary cutaneous marginal zone B-cell lymphoma","volume":"125","author":"Cho-Vega","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"17038","DOI":"10.18632\/oncotarget.14928","article-title":"The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP","volume":"8","author":"Jung","year":"2017","journal-title":"Oncotarget"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/hon.2718","article-title":"High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas","volume":"38","author":"Vela","year":"2020","journal-title":"Hematol Oncol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20090528","article-title":"TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma","volume":"206","author":"Schmitz","year":"2009","journal-title":"J Exp Med"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jid.2018.02.015","article-title":"Panel sequencing shows recurrent genetic FAS alterations in primary cutaneous marginal zone lymphoma","volume":"138","author":"Maurus","year":"2018","journal-title":"J Invest Dermatol"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","article-title":"Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome","volume":"81","author":"Fisher","year":"1995","journal-title":"Cell"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/gim.0b013e3182310b7d","article-title":"Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance","volume":"14","author":"Hsu","year":"2012","journal-title":"Genet Med"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/sj.leu.2403644","article-title":"T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma","volume":"19","author":"Streubel","year":"2005","journal-title":"Leukemia"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1038\/sj.leu.2403122","article-title":"Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT\/MALT1 in MALT lymphomas","volume":"17","author":"Murga Penas","year":"2003","journal-title":"Leukemia"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.0303-6987.2006.00459.x","article-title":"t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B-cell lymphomas","volume":"33","author":"Wongchaowart","year":"2006","journal-title":"J Cutan Pathol"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/s41375-018-0082-4","article-title":"High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations","volume":"32","author":"Pillonel","year":"2018","journal-title":"Leukemia"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","article-title":"The genetic basis of hepatosplenic T-cell lymphoma","volume":"7","author":"McKinney","year":"2017","journal-title":"Cancer Discov"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.3390\/cancers12123539","article-title":"Monomorphic epitheliotropic intestinal T-cell lymphoma in asia frequently shows SETD2 alterations","volume":"12","author":"Tomita","year":"2020","journal-title":"Cancers"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001984","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:01:02Z","timestamp":1749416462000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001984"}},"subtitle":["A Diagnostic Challenge Examined by Genomic Analysis"],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001984","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,21]]}}}